SLC2A1 and ovarian carcinoma: The cellular uptake of glucose-platinum conjugate was reduced to 50%, when the ovarian cancer cell line A2780 (high level of GLUT1 expression) were treated with GLUT1 inhibitor 4, 6-O-ethylidene-α-D-glucose (EDG), indicating that GLUT1 was involved in the uptake of glucose-platinum conjugate.